Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.
Role of SFB in autoimmune arthritis: An example of regulation of autoreactive T cell sensitivity in the gut.
The trees and the forest: Characterization of complex brain networks with minimum spanning trees.
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks.
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice.
Tobacco smoking and excess mortality in multiple sclerosis: a cohort study.
Glutathione in multiple sclerosis: More than just an antioxidant?
What is microglia neurotoxicity (Not)?
Co-Delivery of Autoantigen and B7 Pathway Modulators Suppresses Experimental Autoimmune Encephalomyelitis.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Comparison of Disease Activity in SPMS and PPMS in the Context of Multicenter Clinical Trials.
Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4.
[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode].
The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity.
Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues.
Fluctuations of MS births and UV-light exposure.
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
Robert Whytt, Benjamin Franklin, and the first probable case of multiple sclerosis.
Transplantation of Fas-deficient or wild-type neural stem/progenitor cells (NPCs) is equally efficient in treating experimental autoimmune encephalomyelitis (EAE).
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
Brain Metabolite Changes in Subcortical Regions After Exposure to Cuprizone for 6 Weeks: Potential Implications for Schizophrenia.
Pages
« first
‹ previous
…
291
292
293
294
295
296
297
298
299
…
next ›
last »